Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | -4.09% | -14.81% | -30.51% |
27/03 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
27/03 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | 28.74M 2.4B | Capitalization | 106M 8.82B |
---|---|---|---|---|---|
Net income 2024 * | -40M -3.34B | Net income 2025 * | -30M -2.5B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.68 x |
P/E ratio 2024 * |
-2.8
x | P/E ratio 2025 * |
-4.79
x | Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on GlycoMimetics, Inc.
1 day | -4.09% | ||
1 week | -14.81% | ||
Current month | -45.33% | ||
1 month | -45.33% | ||
3 months | -48.43% | ||
6 months | +42.61% | ||
Current year | -30.51% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 06/21/06 |
Rachel King
FOU | Founder | 64 | 04/03/04 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 17/16/17 |
Patricia Andrews
BRD | Director/Board Member | 66 | 12/17/12 |
Scott Jackson
BRD | Director/Board Member | 60 | 28/18/28 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.64 | -4.09% | 1,015,401 |
25/24/25 | 1.71 | -7.82% | 547,997 |
24/24/24 | 1.855 | +1.09% | 664,799 |
23/24/23 | 1.835 | +1.94% | 1,231,604 |
22/24/22 | 1.8 | -6.49% | 1,477,807 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.51% | 106M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.82% | 22.15B | |
-17.37% | 21.02B | |
-7.98% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- GLYC Stock